Vanguard Group Inc. Raises Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Vanguard Group Inc. raised its position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 2.3% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,510,567 shares of the medical instruments supplier's stock after buying an additional 33,500 shares during the period. Vanguard Group Inc. owned about 6.79% of LeMaitre Vascular worth $82,296,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently modified their holdings of LMAT. Comerica Bank purchased a new stake in shares of LeMaitre Vascular in the 2nd quarter worth about $114,400,000. Congress Asset Management Co. MA lifted its position in shares of LeMaitre Vascular by 36.3% in the 3rd quarter. Congress Asset Management Co. MA now owns 508,379 shares of the medical instruments supplier's stock worth $27,696,000 after purchasing an additional 135,266 shares during the period. Ranger Investment Management L.P. increased its stake in shares of LeMaitre Vascular by 15.8% in the 3rd quarter. Ranger Investment Management L.P. now owns 898,822 shares of the medical instruments supplier's stock worth $48,968,000 after acquiring an additional 122,601 shares in the last quarter. Marshall Wace LLP bought a new position in shares of LeMaitre Vascular in the 2nd quarter worth about $4,254,000. Finally, Conestoga Capital Advisors LLC increased its stake in shares of LeMaitre Vascular by 3.0% in the 3rd quarter. Conestoga Capital Advisors LLC now owns 1,917,581 shares of the medical instruments supplier's stock worth $104,470,000 after acquiring an additional 55,895 shares in the last quarter. 84.64% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts recently issued reports on LMAT shares. Barrington Research increased their price target on shares of LeMaitre Vascular from $66.00 to $69.00 and gave the stock an "outperform" rating in a research note on Wednesday, February 28th. KeyCorp started coverage on shares of LeMaitre Vascular in a research note on Tuesday, February 6th. They issued a "sector weight" rating for the company. Finally, StockNews.com lowered shares of LeMaitre Vascular from a "buy" rating to a "hold" rating in a research note on Sunday, March 31st. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat, LeMaitre Vascular currently has a consensus rating of "Moderate Buy" and a consensus price target of $68.20.

Insider Buying and Selling

In related news, Director John A. Roush sold 7,500 shares of the firm's stock in a transaction that occurred on Thursday, March 7th. The shares were sold at an average price of $69.00, for a total value of $517,500.00. Following the transaction, the director now owns 2,278 shares of the company's stock, valued at $157,182. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. In other news, Director Lawrence J. Jasinski sold 5,110 shares of the business's stock in a transaction on Tuesday, March 5th. The shares were sold at an average price of $67.50, for a total transaction of $344,925.00. Following the completion of the sale, the director now directly owns 5,309 shares of the company's stock, valued at $358,357.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director John A. Roush sold 7,500 shares of the business's stock in a transaction on Thursday, March 7th. The shares were sold at an average price of $69.00, for a total transaction of $517,500.00. Following the sale, the director now directly owns 2,278 shares of the company's stock, valued at $157,182. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 114,036 shares of company stock valued at $7,873,749. 12.40% of the stock is owned by insiders.

LeMaitre Vascular Stock Up 0.9 %

Shares of NASDAQ LMAT traded up $0.56 during trading on Friday, reaching $64.33. 125,863 shares of the company traded hands, compared to its average volume of 99,992. The firm has a 50 day simple moving average of $64.00 and a 200-day simple moving average of $57.21. The stock has a market capitalization of $1.43 billion, a PE ratio of 48.01, a P/E/G ratio of 2.75 and a beta of 0.87. LeMaitre Vascular, Inc. has a 52-week low of $44.27 and a 52-week high of $74.64.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last announced its quarterly earnings results on Tuesday, February 27th. The medical instruments supplier reported $0.38 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.36 by $0.02. The firm had revenue of $48.90 million for the quarter, compared to the consensus estimate of $49.01 million. LeMaitre Vascular had a net margin of 15.56% and a return on equity of 10.57%. The business's quarterly revenue was up 19.3% compared to the same quarter last year. During the same quarter last year, the firm posted $0.25 EPS. As a group, research analysts predict that LeMaitre Vascular, Inc. will post 1.66 EPS for the current year.

LeMaitre Vascular Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, March 28th. Stockholders of record on Thursday, March 14th were issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 0.99%. The ex-dividend date of this dividend was Wednesday, March 13th. This is an increase from LeMaitre Vascular's previous quarterly dividend of $0.14. LeMaitre Vascular's dividend payout ratio (DPR) is presently 47.76%.

LeMaitre Vascular Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.